(NASDAQ:ARTL), SOLANA BEACH, Calif., Aug. 01, 2025 (GLOBE NEWSWIRE) — Artelo Biosciences, Inc. (“Artelo” or the “Company”) (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, dermatologic, or neurological conditions, today announced that it has received written scientific advice from the UK's Medicines and […]

(NasdaqGM:IESC), HOUSTON, Aug. 01, 2025 (GLOBE NEWSWIRE) — IES Holdings, Inc. (or “IES” or the “Company”) (NASDAQ: IESC) today announced financial results for the quarter ended June 30, 2025. Third Quarter 2025 Highlights and Recent Developments Revenue of $890 million for the third quarter of fiscal 2025, an increase of 16% compared with $768 million

New location in Northeast Florida brings store count to 68 statewide and 154 nationwide Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading international provider of consumer cannabis products, today announced the opening of a new medical cannabis dispensary in St. Augustine, Florida. Curaleaf St. Augustine, located at 1280 Ponce De

Artelo Biosciences Receives Favorable UK MHRA Guidance for a Phase 1 Trial of ART12.11, the Company's Proprietary CBD:TMP Cocrystal Being Developed for the Treatment of Anxiety and Depression MHRA indicated ART12.11 may be a candidate for accelerated development via the Innovative Licensing and Access Pathway GlobeNewswire August 01, 2025 SOLANA BEACH, Calif., Aug. 01, 2025

IES Holdings Reports Fiscal 2025 Third Quarter Results GlobeNewswire August 01, 2025 HOUSTON, Aug. 01, 2025 (GLOBE NEWSWIRE) — IES Holdings, Inc. (or “IES” or the “Company”) (NASDAQ: IESC) today announced financial results for the quarter ended June 30, 2025. Third Quarter 2025 Highlights and Recent Developments Revenue of $890 million for the third quarter

NEW YORK, NY / ACCESS Newswire / August 1, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Bruker Corporation ("Bruker Corporation") (NASDAQ:BRKR) concerning possible violations of federal securities laws. On July 21, 2025, Bruker announced disappointing preliminary results for the second quarter, ended June 30, 2025. The Company disclosed

NEW YORK, NY / ACCESS Newswire / August 1, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Otis Worldwide Corporation ("Otis Worldwide Corporation") (NYSE:OTIS) concerning possible violations of federal securities laws. On July 23, 2025, Otis reported its second quarter fiscal 2025 earnings, unveiling net sales for the quarter

ZHUHAI, China, Aug. 01, 2025 (GLOBE NEWSWIRE) — From July 23 to 25, the Chinese-language version of the UFI-VMS education programme was held for the first time in the Guangdong-Macao In-Depth Co-operation Zone in Hengqin (the “Co-operation Zone”), co-organised by the Global Association of the Exhibition Industry (UFI) and the Venue Management Association (VMA), jointly

Internationally Certified MICE Training Programme Launched in the GBA, Strengthening Talent Integration Between Macao and Hengqin GlobeNewswire August 01, 2025 ZHUHAI, China, Aug. 01, 2025 (GLOBE NEWSWIRE) — From July 23 to 25, the Chinese-language version of the UFI-VMS education programme was held for the first time in the Guangdong-Macao In-Depth Co-operation Zone in Hengqin

NEW YORK, NY / ACCESS Newswire / August 1, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of V.F. Corporation ("V.F. Corporation") (NYSE:VFC) concerning possible violations of federal securities laws. On May 21, 2025, VFC issued a press release announcing that the company’s fourth quarter fiscal 2025 results failed to